Related Experiment Videos

Mortality Stratification With Pediatric SOFA and Persistent Inflammation, Immunosuppression, and Catabolism Syndrome

Shin Tsubokura1, Norihiko Tsuboi1, Saki Endo1

  • 1Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan.

Insights

Combining the pediatric sequential organ failure assessment (pSOFA) score and persistent inflammation, immunosuppression, and catabolism syndrome in pediatrics (PIICS-p) criteria improves mortality risk stratification in critically ill children. This approach identifies high-risk patients early and predicts late mortality.

Area of Science:

  • Pediatric critical care medicine
  • Clinical risk stratification
  • Prognostic modeling

Background:

  • Persistent inflammation, immunosuppression, and catabolism syndrome in pediatrics (PIICS-p) criteria identify pediatric intensive care unit (PICU) patients with poor long-term prognosis.
  • Pediatric sequential organ failure assessment (pSOFA) score is a validated predictor of short-term mortality in critically ill children.

Purpose of the Study:

  • To evaluate the combined utility of pSOFA score and PIICS-p criteria for comprehensive risk stratification in critically ill children.
  • To determine if integrating these measures improves prediction of mortality compared to using them individually.

Main Methods:

  • A retrospective cohort study included 285 pediatric patients with prolonged PICU stays (≥15 days).
  • Patients were assessed on PICU day 14 for high (>8) or low pSOFA scores and stratified by the presence or absence of PIICS-p criteria.
  • Primary outcomes included in-hospital mortality and time from PICU day 14 to death.

Main Results:

  • Overall mortality was 47% in the high pSOFA group, 32% in the low pSOFA/PIICS-p group, and 10% in the low pSOFA/non-PIICS-p group (p < 0.001).
  • High pSOFA (HR 6.33) and low pSOFA/PIICS-p (HR 3.14) were significant independent risk factors for mortality.
  • Kaplan-Meier survival analysis revealed significant differences among the three risk groups, with distinct early and late mortality patterns.

Conclusions:

  • The integration of pSOFA score and PIICS-p criteria effectively stratifies critically ill children into three distinct mortality risk groups.
  • This combined approach allows for early identification of patients at high risk for both short-term and late mortality, even among those initially appearing to have a low acute risk.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...